Global Acute Lymphoblastic Leukemia CAR T-Cell Therapy Insights, 2017-2030: Current Practices, Marketed & Emerging Drugs, Pipeline Activities, Competitive Intelligence
Autolus Therapeutics plc - American Depositary Shares (AUTL)
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am
Check Earnings Report
US:NASDAQ Investor Relations:
autolus.com/investor-relations
Company Research
Source: PR Newswire
DUBLIN, April 15, 2020 /PRNewswire/ -- The "CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insights and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.This report delivers an in-depth understanding of the CAR T-Cell Therapy use for Acute Lymphoblastic Leukemia as well as the CAR T-Cell Therapy market trends for Acute Lymphoblastic Leukemia in the 6MM i.e., United States and EU5 (Germany, Spain, Italy, France and the United Kingdom).The report provides current treatment practices, emerging drugs, market share of various CAR T-Cell Therapies for Acute Lymphoblastic Leukemia, the individual therapies, current and forecasted market size from 2017 to 2030 segmented by EU5 and the United States markets. The report also covers current Acute Lymphoblastic Leukemia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.Study
Show less
Read more
Impact Snapshot
Event Time:
AUTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUTL alerts
High impacting Autolus Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AUTL
News
- Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026 [Yahoo! Finance]Yahoo! Finance
- Autolus Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
- Autolus Therapeutics (NASDAQ:AUTL) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.MarketBeat
- CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™PR Newswire
- CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™PR Newswire
AUTL
Earnings
- 11/12/25 - Miss
AUTL
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/13/26 - Form SCHEDULE
- 1/26/26 - Form 424B3
- AUTL's page on the SEC website